Catapult (ASX:CAT) 1H20 results & outlook
03 Mar 2020 - Catapult Limited (ASX:CAT) CEO, Will Lopes discusses 1H20 results and outlook.
03Mar
02Mar
InPayTech (ASX:IP1) 1H20 results & outlook
02 Mar 2020 - Integrated Payment Technologies Limited (ASX:IP1) CEO, Dean Martin, discusses 1H20 results, customers numbers and take up for the company's ClickSuper and PayVu systems and integration with accounting platforms.
28Feb
Washington H. Soul Pattinson and Company Limited (ASX:SOL) stewardship and outlook
28 Feb 2020 - Washington H. Soul Pattinson and Company Limited (ASX:SOL) Managing Director, Todd Barlow provides a portfolio update and talks about the approach to investment that has enabled the company to outperform over decades.
27Feb
NetLinkz (ASX:NET) agreement to monitor water quality in Sichuan Province
27 Feb 2020 - NetLinkz Limited (ASX:NET) Executive Chairman and CEO, James Tsiolis talks about the significance of the company's agreement to provides its Virtual Secure Network to a World Bank-sponsored initiative to improve water sanitation services in selected areas of the Deyang Municipality of Sichuan Province.
27Feb
Ingenia Communities Group (ASX:INA) 1H20 results & outlook
27 Feb 2020 - Ingenia Communities Group Limited (ASX:INA) CFO, Scott Noble, discusses 1H20 results, the company's portfolio and the demand for seniors accommodation.
26Feb
Renergen (ASX:RLT) natural gas and helium producer
26 Feb 2020 - Renergen Limited (ASX:RLT) Managing Director and CEO, Stefano Marani provides an update on recent drilling results at the company's Virginia Gas Project in South Africa, what’s planned for this year and the potential to bring forward a second production well.
25Feb
Noxopharm (ASX:NOX) LuPIN trial in prostate cancer
25 Feb 2020 - Noxopharm Limited (ASX:NOX) Chief Medical Officer, Dr Gisela Mautner, talks about results from the company's LuPIN trial in prostate cancer, evaluating its lead product candidate, Veyonda, in combination with 177Lu-PSMA-617, a radiopharmaceutical therapy, in 56 patients with late-stage prostate cancer.
19Feb
BluGlass (ASX:BLG) discusses laser diodes and business opportunities
19 Feb 2020 - BluGlass (ASX:BLG) Managing Director, Giles Bourne talks about the opportunities that laser diodes represent for the company, following the Photonics West Conference.
13Feb
Centuria Capital Group (ASX:CNI) 1H20 results & outlook
13 Feb 2020 - Centuria Capital Group (ASX:CNI) Joint CEO, John McBain talks 1H20 results & outlook, including the contribution from recent acquisitions as group AUM now exceeds $7.3B.
12Feb
Mayur Resources (ASX:MRL) – PNG resource developer
12 Feb 2020 - Mayur Resources Limited (ASX:MRL) Managing Director, Paul Mulder provides an update on the company's PNG projects, which span industrial minerals, power generation, coal, copper and gold.